<i>In Vitro</i> Hippocampal Electrophysiology and <i>in Vivo</i> Quantitative EEG Revealed Robust Neurophysiological Effects of the Antivertigo-Agent Vertigoheel<sup>®</sup> in a Rat Study — Oak Academic Publishing
Research ArticleOpen AccessGoogle Scholar indexed
<i>In Vitro</i> Hippocampal Electrophysiology and <i>in Vivo</i> Quantitative EEG Revealed Robust Neurophysiological Effects of the Antivertigo-Agent Vertigoheel<sup>®</sup> in a Rat Study
Justus Liebig University Giessen, Giessen, Germany
Vertigo is a common symptom with impact on daily life. Vertigoheel ® (VH-04) has demonstrated to be effective for Vertigo in former studies. This paper aims to investigate the mode of action of the medicinal product VH-04 in the rat brain. In an in vitro study neurophysiological recording from hippocampal slices from adult male Sprague Dawley ® rats was performed in order to substantiate a possible direct effect on the brain of VH-04 in different concentrations. In an in vivo cross-over study with 11 Fischer 344 ® rats, a neurophysiological method was applied to systemically analyse VH-04’s activity in the rat brain. This method combines quantitative assessments of telemetrically transmitted field potentials after drug treatment with subsequent discriminant analysis to classify the compound. The database used for the analysis of classification contained numerous chemicals and medicinal products of different dosages, all tested in the same paradigm, which is continuous wireless monitoring of the EEG of freely moving rats before and after drug intake. Following single stimuli on the Schaffer collaterals in the presence of VH-04 in different concentrations, in vitro responses of pyramidal cells increased depending on the VH-04 concentration (0.25 - 4 ml/L). Results were statistically significant for concentrations above 2.5 ml/L. Long-term potentiation was only marginally affected. Out of several specific glutamate receptor antagonists the effect of VH-04 was only antagonized by AMPA and kainic acid receptor-mediated signalling. Their enhancement indicates better information processing in the hippocampus, a brain structure primarily involved in memory processes. The in vivo characterisation of VH-04-induced changes in EEG-signatures of four brain areas (the frontal cortex (FC), the hippocampus (HC), the striatum (ST) and the reticular formation (RF)) revealed a dose-dependent attenuation of delta, theta, alpha 2 and beta 1 waves. The subsequent discriminant function analysis classified the VH-04 EEG-signature into a subset of cognition-enhancing medicinal products.
Blakley, B.W. and Goebel, J. (2001) The Meaning of the Word “Vertigo”. Otolaryngology—Head and Neck Surgery, 125, 147-150. https://doi.org/10.1067/mhn.2001.117869
Neuhauser, H.K. and Lempert, T. (2009) Vertigo: Epidemiologic Aspects. Seminars in Neurology, 29, 473-481. https://doi.org/10.1055/s-0029-1241043
Fernandez, L., Breinbauer, H.A. and Delano, P.H. (2015) Vertigo and Dizziness in the Elderly. Frontiers in Neurology, 6, 114. https://doi.org/10.3389/fneur.2015.00144
Weiser, M., Stroesser, W. and Klein, P. (1998) Homeopathic vs. Conventional Treatment of Vertigo. Archives Otolaryngology—Head and Neck Surgery, 124, 879-885. https://doi.org/10.1001/archotol.124.8.879
Klopp, R., Niemer, W. and Weiser, M. (2005) Microcirculatory Effects of a Homeopathic Preparation in Patients with Mild Vertigo: An Intravital Microscopic Study. Microvascular Research, 69, 10-16. https://doi.org/10.1016/j.mvr.2004.11.005
Wink, M. (2008) Evolutionary Advantage and Molecular Modes of Action of Multi-Component Mixtures Used in Phytomedicine. Current Drug Metabolism, 9, 996- 1009. https://doi.org/10.2174/138920008786927794
Keith, C.T., Borisy, A.A. and Stockwell, B.R. (2005) Multicomponent Therapeutics for Networked Systems. Nature Reviews Drug Discovery, 4, 71-78. https://doi.org/10.1038/nrd1609
Groten, J.P., Butler, W., Feron, V.J., Kozianowski, G., Renwick, A.G. and Walker, R. (2000) An Analysis of the Possibility for Health Implications of Joint Actions and Interactions between Food Additives. Regulatory Toxicology and Pharmacology, 31, 77-91. https://doi.org/10.1006/rtph.1999.1356
Wagner, H. and Ulrich-Merzenich, G. (2009) Synergy Research: Approaching a New Generation of Phytopharmaceuticals. Phytomedicine, 16, 97-110. https://doi.org/10.1016/j.phymed.2008.12.018
Cassee, F.R., Groten, J.P., Van-Bladeren, P.J. and Feron, V.J. (1998) Toxicological Evaluation and Risk Assessment of Chemical Mixtures. Critical Reviews in Toxicology, 28, 73-101. https://doi.org/10.1080/10408449891344164
Berenbaum, M.C. (1989) What Is Synergy? Pharmacological Reviews, 41, 93-141.
Chou, T.C. and Talalay, P. (1984) Quantitative Analysis of Dose-Effect Relationships: The Combined Effects of Multiple Drugs or Enzyme Inhibitors. Advances in Enzyme Regulation, 22, 27-55. https://doi.org/10.1016/0065-2571(84)90007-4
Dimpfel, W., Schombert, L., Vega-Morales, T. and Wiebe, J. (2016) Neuropharmacological Characterization of Extracts from Rhodiola rosea, Oenothera paradoxa and Paullinia cupana in Comparison to Caffeine. Pharmacology & Pharmacy, 7, 290-303. https://doi.org/10.1016/j.jep.2015.11.036
Multitarget
Fast Fourier Transformation
Dimpfel, W., Dalhoff, B., Hofmann, W. and Schlueter, G. (1994) Electrically Evoked Potentials in the Rat Hippocampus Slice in the Presence of Aminophylline Alone and in Combination with Quinolones. European Neuropsychopharmacology, 4, 151-156. https://doi.org/10.1016/0924-977X(94)90009-4
Dimpfel, W. (2006) Different Anticonvulsive Effects of Hesperidin and Its Aglycone Hesperetin on Electrical Activity in the Rat Hippocampus in Vitro. Journal of Pharmacy and Pharmacology, 58, 375-379. https://doi.org/10.1211/jpp.58.3.0012
Dimpfel, W. (2015) Drug Discovery and Translational Medicine Based on Neuro-Physiological Techniques. A Holistic Approach to Saving Animals. Books on Demand, Norderstedt.
Haas, H.L., Schaerer, B. and Vosmansky, M. (1979) A Simple Perfusion Chamber for the Study of Nervous Tissue Slices in Vitro. Journal of Neuroscience Methods, 1, 323-325. https://doi.org/10.1016/0165-0270(79)90021-9
Schiff, S.J. and Somjen, G.G. (1985) The Effects of Temperature on Synaptic Transmission in Hippocampal Tissue Slices. Brain Research, 345, 279-284. https://doi.org/10.1016/0006-8993(85)91004-2
Lynch, G. and Schubert, P. (1980) The Use of in Vitro Brain Slices for Multidisciplnary Studies of Synaptic Function. Annual Review of Neuroscience, 3, 1-22. https://doi.org/10.1146/annurev.ne.03.030180.000245
Dimpfel, W. (2008) Pharmacological Modulation of Dopaminergic Brain Activity and Its Reflection in Spectral Frequencies of the Rat Electropharmacogram. Neuropsychobiology, 58, 178-186. https://doi.org/10.1159/000191124
Dimpfel, W. (2003) Preclinical Data Base of Pharmaco-Specific Rat EEG Fingerprints (Tele-Stereo-EEG). European Journal of Medical Research, 8, 199-207.
Dimpfel, W. and Schober, F. (2001) Norepinephrine, EEG Theta Waves and Sedation. Brain Pharmacology, 1, 89-97.
Dimpfel, W. (2005) Pharmacological Modulation of Cholinergic Brain Activity and Its Reflection in Special EEG Frequency Ranges from Various Brain Areas in the Freely Moving Rat (Tele-Stereo-EEG). European Neuropsychopharmacology, 15, 673-682. https://doi.org/10.1016/j.euroneuro.2005.03.006
Bennett, D.A., Lehmann, J., Bernard, P.S., Liebman, J.M., Williams, M., Wood, P.L., Boast, C.A. and Hutchison, A.J. (1990) CGS 19755: A Novel Competitive N-methyl-D-aspartate (NMDA) Receptor Antagonist with Anticonvulsant Anxiolytic and Anti-Ischemic Properties. Progress in Clinical and Biological Research, 361, 519-524.
Gill, R., Nordholm, L. and Lodge, D. (1992) The Neuroprotective Actions of 2,3-dihydroxy-6-nitro-7sulfamoyl-benzo(F)quinoxaline (NBQX) in Rat Focal Ischaemia Model. Brain Research, 580, 35-43. https://doi.org/10.1016/0006-8993(92)90924-X
Szabados, T., Gigler, G., Gacsályi, I., Gyertyan, I. and Lévay, G. (2001) Comparison of Anticonvulsive and Acute Neuroprotective Activity of Three 2,3-benzodiazepine Compounds, GYKI 52466, GYKI 53405, and GYKI 53655. Brain Research Bulletin, 55, 387-391. https://doi.org/10.1016/S0361-9230(01)00516-0
Pelletier, J.C., Hesson, D.P., Jones, K.A. and Costa, A.M. (1996) Substituted 1, 2-dihydrophtalazines: Potent, Selective, and Noncompetitive Inhibitors of the AMPA Receptor. Journal of Medicinal Chemistry, 39, 343-346. https://doi.org/10.1021/jm950740w
More, J.C., Troop, H.M., Dolman, N.P. and Jane, D.E. (2003) Structural Requirements for Novel Willardiine Derivatives Acting as AMPA and Kainate Receptor Antagonists. British Journal of Pharmacology, 138, 1093-1100. https://doi.org/10.1038/sj.bjp.0705148
Xi, Z.X., Baker, D.A., Shen, H., Carson, D.S. and Kalivas, P.W. (2002) Group II Metabotropic Glutamate Receptors Modulate Extracellular Glutamate in the Nucleus Accumbens. Journal of Pharmacology and Experimental Therapeutics, 300, 162-171. https://doi.org/10.1124/jpet.300.1.162
Kohara, A., Toya, T., Tamura, S., Watabiki, T., Nagakura, Y., Shitaka, Y., Hayashibe, S., Kawabata, S. and Okada, M. (2005) Radioligand Binding Properties and Pharmacological Characterization of 6-amino-N-cyclohexyl-N,3-dimethylthiazolo [3,2-a]benzimidazole-2-carboxamide (YM-298198), a High-Affinity, Selective, and Noncompetitive Antagonist of Metabotropic Glutamate Receptor Type 1. Journal of Pharmacology and Experimental Therapeutics, 315, 163-169. https://doi.org/10.1124/jpet.105.087171
Thomas, N.K., Jane, D.E., Tse, H.W. and Watkins, J.C. (1996) Alpha-Methyl Derivatives of Serine-O-phospate as Novel, Selective Competitive Metabotropic Glutamate Receptor Antagonists. Neuropharmacology, 35, 637-42. https://doi.org/10.1016/0028-3908(96)84635-1
Clewett, D., Sakaki, M., Nielsen, S., Petzinger, G. and Mather, M. (2016) Nordrenergic Mechanisms of Arousal’s Bidirectional Effects on Episodic Memory. Neurobiology of Learning and Memory, 137, 1-14. https://doi.org/10.1016/j.nlm.2016.10.017
Chen, Y.C., Duann, J.R., Chuang, S.W., Lin, C.L., Ko, L.W., Jung, T.P. and Lin, C.T. (2010) Spatial and Temporal EEG Dynamics of Motion Sickness. Neuroimage, 49, 2862-2870. https://doi.org/10.1016/j.neuroimage.2009.10.005
Morawiec-Baida, A., Lukomski, M. and Latkowski, B. (1993) The Clinical Efficacy of Vertigoheel in the Treatment of Vertigo of Various Etiology. Panminerva Medica, 35, 101-104.
Schautzer, F., Hamilton, D., Kalla, R., Strupp, M. and Brandt, T. (2003) Spatial Memory Deficits in Patients with Chronic Bilateral Vestibular Failure. Annals of the New York Academy of Sciences, 1004, 316-324. https://doi.org/10.1196/annals.1303.029
Brandt, T., Schautzer, F., Hamilton, D.A., Bruning, R., Markowitsch, H.J., Kalla, R., Darlington, C., Smith, P. and Strupp, M. (2005) Vestibular Loss Causes Hippocampal Atrophy and Impaired Spatial Memory in Humans. Brain, 128, 2732-2741. https://doi.org/10.1093/brain/awh617
Bachtold, D., Baumann, T., Sandor, P.S., Kritos, M., Regard, M. and Brugger, P. (2001) Spatial- and Verbal-Memory Improvement by Cold-Water Caloric Stimulation in Healthy Subjects. Experimental Brain Research, 136, 128-132. https://doi.org/10.1007/s002210000588
Wilkinson, D., Nicholls, S., Pattenden, C., Kilduff, P. and Milberg, W. (2008) Galvanic Vestibular Stimulation Speeds Visual Memory Recall. Experimental Brain Research, 189, 243-248. https://doi.org/10.1007/s00221-008-1463-0
Moser, D.J., Hoth, K.F., Robinson, R.G., Paulsen, J.S., Sinkey, C.A., Benjamin, M.L., Schultz, S.K. and Haynes, W.G. (2004) Blood Vessel Function and Cognition in Elderly Patients with Atherosclerosis. Stroke, 35, e369-e372. https://doi.org/10.1161/01.STR.0000145050.35039.51
Marshall, R.S. and Lazar, R.M. (2011) Pumps, Aqueducts, and Drought Management: Vascular Physiology in Vascular Cognitive Impairment. Stroke, 42, 221-226. https://doi.org/10.1161/STROKEAHA.110.595645
Yoshiike, Y., Kimura, T., Yamashita, S., Furudate, H., Mizoroki, T., Murayama, M. and Takashima, A. (2008) GABA (A) Receptor-Mediated Acceleration of Aging-Associated Memory Decline in APP/PS1 Mice and Its Pharmacological Treatment by Picrotoxin. PLoS ONE, 3, e3029. https://doi.org/10.1371/journal.pone.0003029
Dingledine, R. (1984) Brain Slices. Plenum Press, New York, London. https://doi.org/10.1007/978-1-4684-4583-1
Dimpfel, W. (1995) Effects of Memantine on Synaptic Transmission in the Hippocampus in Vitro. Arzneimittelforschung, 45, 1-5.
Sachidhanandam, S., Blanchet, C., Jeantet, Y., Cho, Y.H. and Mulle, C. (2009) Kainate Receptors Act as Conditional Amplifiers of Spike Transmission at Hippocampal Mossy Fiber Synapses. Journal of Neuroscience, 29, 5000-5008. https://doi.org/10.1523/JNEUROSCI.5807-08.2009
Johnson, K.A., Conn, P.J. and Niswender, C.M. (2009) Glutamate Receptors as Therapeutic Targets for Parkinson’s Disease. CNS & Neurological Disorders—Drug Targets, 8, 475-491. https://doi.org/10.2174/187152709789824606